UT-155 is a selective and potent androgen receptor (AR) antagonist, exhibiting a binding affinity (Ki) of 267 nM for the AR ligand-binding domain. This small molecule is a valuable research tool for investigating AR signaling in prostate cancer and other androgen-dependent pathologies, applicable in both in vitro and in vivo experimental models.
